Unichem Laboratories mentioned its board has advisable a dividend of ₹4 (200%) per fairness share of ₹2/- every, for FY22, topic to approval of shareholders on the ensuing Annual Basic Assembly (AGM). Shares of Unichem Labs rallied greater than 17% to ₹278 apiece on the BSE in Monday’s buying and selling session.
“We wish to inform you that Board of Administrators at its assembly held on Friday, Might 27, 2022 has Advisable Dividend of ₹4/-(200%) per fairness share of Rs.2/- every, for the 12 months ended March 31, 2022, topic to approval of shareholders on the ensuing Annual Basic Assembly,” the pharma firm knowledgeable in an alternate submitting on Friday.
Unichem Laboratories on Friday mentioned its consolidated web revenue stood at ₹71 crore for the fourth quarter ended March 31, 2022. The drug agency had reported a web lack of ₹41 lakh within the January-March quarter of 2020-21 fiscal. Income from operations rose to ₹370 crore within the fourth quarter as in opposition to ₹274 crore within the year-ago interval.
For the total monetary 12 months 2021-22, the corporate reported a web revenue of ₹33 crore as in opposition to ₹34 crore in FY21. Income from operations rose to ₹1,270 crore for FY22 as in opposition to ₹1,235 crore within the previous fiscal.
The pharma inventory is down over 18% in a 12 months’s interval, whereas the counter is up almost 10% in 2022 (YTD) to date.
Supply: Live Mint